CBT-I Improves Sleep Pressure as Measured by Stage 2 sleep K-complexes
K-complexes are a distinct brain wave pattern in Stage 2 sleep that indicate the brain is losing awareness of the external environment as it descends into deep sleep and dream…
Blog
Napping In Insomnia Patients Undergoing CBT-I
CBT-I is the gold standard treatment for chronic insomnia, and there is clear evidence that short recuperative naps increase alertness and reduce fatigue. However, there is a lack of consensus…
CBT-I Reduces Insomnia and Improves Sleep Quality During Pregnancy
Insomnia and sleep problems are common in pregnancy. A recent study examined the efficacy of CBT-I in pregnancy. A randomized controlled trial evaluated CBT-I (n = 32) compared to a treatment…
Factors Predicting Insomnia Remission After Digital (online) CBT-I
Digital CBT-I (D-CBT-I) has been shown to be as efficacious as face-to-face CBT-I. However, not all patients achieve insomnia remission after D-CBT-I. A recent study explored the factors influencing the…
Insomnia Patients are Fatigued But Not Sleepy
Insomnia patients often report fatigue and sleepiness as daytime consequences of insomnia. A recent study investigated subjective daytime fatigue and sleepiness in insomnia patients. The study sample of 105 healthy…
Risk/Benefit Analysis of Five Classes of Sleep Medications
A study published in the Journal of Sleep Research examined the safety and efficacy (e.g., risk–benefit ratio) for five classes of prescription hypnotic medications approved by the FDA for insomnia.…
Sleep Duration and Mortality Risk Sex Differences
A previous meta-analysis assessing the relationship between sleep duration and health found significantly increased mortality for ≥ 9 hours of sleep, and increased cancer mortality for ≥ 9 hours of sleep. In a new…
Use of BZD-Z Drugs for Insomnia In Older Adults
Although multiple insomnia treatment practice guidelines recommend that benzodiazepines (BZD) and benzodiazepine receptor agonist “Z” drugs such as Ambien/zolpidem (Z) be prescribed at the lowest dose for 2–4 weeks, a surprising…
Psychedelics are a Revolutionary Treatment for Depression.
Many insomnia patients have major depression that is resistant to treatment. Fortunately, recent studies from psychedelic medicine research centers at Johns Hopkins, Duke, NYU, UCLA, Michigan, Harvard, and Berkeley have…
New Evidence-Based Insomnia Treatment Guidelines
Updated guidelines for the treatment of insomnia have recently been established by the European Sleep Society, the largest sleep research society in the world. These clinical guidelines are based on…